Europe Prosthetic Heart Valves Market

Europe Prosthetic Heart Valves Market Size (2024 to 2029)

The Prosthetic Heart Valves Market Size in Europe is valued at USD 1.80 billion in 2024. This value is expected to be growing at a CAGR of 12.66% to reach USD 3.27 billion by 2029.

The rise in heart surgeries majorly accelerates the prosthetic heart valves market in Europe. Additionally, factors such as rising awareness levels related to the initial diagnosis and available treatment for heart valve disorders, rapid growth in the aging population, and Y-O-Y growth in valvular heart diseases further accelerate the European market prosthetic heart valves. Favorable reimbursement policies, an increasing number of mergers and acquisitions, and a rise in collaborations and partnerships, increasing the occurrence rate of different chronic diseases help the market grow further.

High costs, strict government regulations for the heart valves, and professional surgeons' shortage are some of the constraints for the market growth.

This market research report has been Europe Prosthetic Heart Valves Market segmented and sub-segmented into the following categories.

• By Product: Mechanical Heart Valve, Tissue Heart Valve, Stented Tissue Heart Valve, Stentless Tissue Heart Valve, Transcatheter Heart Valve
• By Country: UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe.

Regionally, Europe is one of the significant market players holding the second highest market share at present. Despite a below-average CAGR, the market is standing strong due to the immense scope of research in the region. The region is mostly at its epitome of development, and companies in the area are turning their attention towards research regarding advanced results.

The United Kingdom is anticipated to lead the European market of prosthetic heart valves over the review period. An increase in acquisition rate and new product device approvals and ease of implantation, and increasing patient population are likely to boost the market. Increasing consciousness about heart valve diseases is to bolster the market.

Germany is expected to have rapid growth in the market due to growing healthcare; enhancements in healthcare infrastructure are to drive the market. A massive number of product approvals for the product devices, increasing discretionary expenses, and increasing requirements for minimally invasive surgeries accelerate the market during the assessment.

France and Italy are expected to have considerable growth in the forthcoming years. Increasing per capita income and rising funds and investments towards the research activities for the heart valves' enhancement is to augment this region's development.

Some of the top companies leading the Europe Prosthetic Heart Valves Market Profiled in the Report are Corvia Medical, CardioKinetix, Biomerics LLC, Lepu Medical Technology, XELTIS BV, Comed BV, HLT, Meril Life Sciences, SYMETIS SA, and Transcatheter Technologies GmbH.